Acquisition by Pirozzi Gianluca of 4100 shares of Timber Pharmaceuticals subject to Rule 16b-3
TMBRDelisted Stock | USD 1.72 0.01 0.58% |
Slightly above 53% of Timber Pharmaceuticals' investor base is interested to short. The analysis of current outlook of investing in Timber Pharmaceuticals suggests that many traders are impartial regarding Timber Pharmaceuticals' prospects. Timber Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Timber Pharmaceuticals. Many technical investors use Timber Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Timber |
Filed transaction by Timber Pharmaceuticals In director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Timber Pharmaceuticals Fundamental Analysis
We analyze Timber Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Timber Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Timber Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Debt To Equity
Debt To Equity Comparative Analysis
Timber Pharmaceuticals is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Timber Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Timber Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Timber Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Timber Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Timber Pharmaceuticals Related Equities
NTRB | Nutriband | 34.88 | ||||
CRIS | Curis | 4.89 | ||||
TPST | Tempest Therapeutics | 4.55 | ||||
SLRX | Salarius Pharmaceuticals | 1.87 | ||||
ARTL | Artelo Biosciences | 1.69 | ||||
GOVX | GeoVax Labs | 1.42 | ||||
SABS | SAB Biotherapeutics | 1.36 | ||||
ENTX | Entera Bio | 2.41 | ||||
SNTI | Senti Biosciences | 2.63 | ||||
QNRX | Quoin Pharmaceuticals | 30.51 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Timber Stock
If you are still planning to invest in Timber Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Timber Pharmaceuticals' history and understand the potential risks before investing.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |